Skip to main content
Premium Trial:

Request an Annual Quote

Eidogen-Sertanty To Use Informatics Platform in Collaboration with KAI Pharmaceuticals

NEW YORK, Oct. 18 (GenomeWeb News) - Eidogen-Sertanty said today that it has entered into an informatics-based collaboration with drug-discovery firm KAI Pharmaceuticals.

 

Under the terms of the collaboration, which will focus on the development of protein kinase C modulators, Eidogen-Sertanty will use its Target Informatics Platform and its EVE comparative visualization software to perform structural characterization and comparative binding site analysis for PKC regulatory domains.

 

KAI is developing modulators of PKCs for a variety of human diseases, and has a lead product in clinical development for acute cardiovascular diseases. The collaboration is expected to improve the pharmacophore-based design of modulators of PKC activity, Eidogen-Sertanty said.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.